Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000277.1:c.1200-2A>G

CA16020965

862570 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: d672dbe7-a194-4f0f-a06b-2c83e1d553bb

HGVS expressions

NM_000277.1:c.1200-2A>G

ENST00000553106.6:c.1200-2A>G

ENST00000307000.7:c.1185-2A>G

ENST00000549247.6:n.959-2A>G

ENST00000551114.2:n.862-2A>G

ENST00000553106.5:c.1200-2A>G

ENST00000635477.1:n.304-2A>G

ENST00000635528.1:n.715-2A>G

NM_000277.2:c.1200-2A>G

NM_001354304.1:c.1200-2A>G

NM_000277.3:c.1200-2A>G

NM_001354304.2:c.1200-2A>G

NC_000012.12:g.102840517T>C

CM000674.2:g.102840517T>C

NC_000012.11:g.103234295T>C

CM000674.1:g.103234295T>C

NC_000012.10:g.101758425T>C

NG_008690.1:g.82086A>G

NG_008690.2:g.122894A>G

Pathogenic

PP4_Moderate PM2 PVS1

PM3

Evidence Links 2

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.1200-2A>G variant in PAH is a null variant (canonical - 2 splice site); Loss of function is a known mechanism of disease, exon skipping disrupts reading frame and is predicted to undergo NMD (not located in last 50bp of preliminary exon). Coding exon 12/13 is present in biologically-relevant transcript. This variant has been reported in 2 individuals with PKU (BH4 deficiency excluded, PMID: 21147011, 24301756). This variant is absent in population databases. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PP4_Moderate.

PP4_Moderate

IVS11-2A>G is seen in 2 PKU patients. BH4 deficiency was ruled out in 1 patient with assessment of PAH gene and genes of the BH4 synthesis/recycling pathways (PTS and QDPR. PMID: 21147011, PMID: 24301756

Forty Iranian patients with clinical and biochemically confirmed PKU were enrolled. The exons were sequenced directly. IVS11-2A>G was identified on 2 alleles in 1 patient with classic PKU (1620 uM pre-treatment Phe level). PubMed:24301756

588 hyperphenylalaninemic patients were investigated. Assessment included PAH gene and genes of the BH4 synthesis/recycling pathways (PTS and QDPR). IVS11-2A>G is seen in 1 PKU patient. PubMed:21147011

PM2

Absent from ExAC, gnomAD, 1000G, ESP

PVS1

Null variant (canonical - 2 splice site) where LOF is a known mechanism of disease, exon skipping disrupts reading frame, and is predicted to undergo NMD (not located in last 50bp of preliminary exon). Coding exon 12/13 is present in biologically-relevant transcript.

PM3

Detected with IVS10-7C>A (not in ClinVar, PAH EP=LP)

Detected with IVS10-7C>A (not in ClinVar, PAH EP = VUS) PubMed:21147011

Approved on: 2020-08-10

Published on: 2021-09-26

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.